Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea after starting Wegovy is one of the more common gastrointestinal effects people notice in the first few weeks of treatment. It tends to appear shortly after an injection or following a dose increase, and for most people it settles down as the body adjusts. It is still a prescription-only medicine, and a prescriber weighs up your full health picture before recommending it — but if loose stools have caught you off guard, here is a clear account of what is happening and what to do about it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy contains semaglutide, a GLP-1 receptor agonist that slows the rate at which the stomach empties food into the small intestine. That deliberate slowing is central to how the medicine reduces appetite, but it also changes the rhythm of the whole digestive tract. Some people find the gut responds by speeding up in other ways, producing loose stools or urgency. The NHS semaglutide medicines page lists diarrhoea among the common side effects, alongside nausea, vomiting, constipation and indigestion.
Dose increases are the most reliable trigger. The standard escalation starts at 0.25 mg and climbs through several steps to a maintenance dose, with each step giving the digestive system a fresh signal to adapt. Bowel changes at each new level are not a sign that something has gone wrong, they are often the body's first response to an altered gut-hormone pattern. The pattern tends to repeat more mildly as you go higher, because the gut has already done most of its adapting. For a broader look at the full range of gastrointestinal effects linked to the injection, the Wegovy side effects overview covers the picture in more detail.
Hydration is the first priority. Loose stools lose fluid fast, and even moderate dehydration makes nausea worse and energy lower, a particularly unhelpful combination when you are already adjusting to the medicine. Plain water, diluted squash and oral rehydration sachets all work; large quantities of caffeine or alcohol do not help and may irritate an already-unsettled gut.
Meal choices matter too. Smaller portions eaten more slowly reduce the volume hitting an already-altered digestive system in one go. High-fat and very spicy foods are more likely to provoke urgency, particularly in the first few weeks. Some people find that timing meals further from the injection day helps, though this varies. If you want more granular guidance on food-related triggers, what tends to make diarrhoea worse after eating on Wegovy goes into the specifics. Over-the-counter loperamide is used by some people for occasional relief, but discuss this with a pharmacist or prescriber before using it regularly alongside semaglutide.
Give things a little time. A prescriber or pharmacist is the right person to talk to if loose stools are significantly affecting your daily life, they can consider whether a slower titration, a brief dose pause, or further assessment would help. That conversation is exactly what the clinical review at nume's consultation is designed for.
Most diarrhoea on Wegovy resolves without intervention, but certain patterns warrant a call to your GP, prescriber or 111 promptly. Contact a clinician the same day if you notice any of the following: diarrhoea lasting more than five or six days without improvement; signs of dehydration (dark or very infrequent urination, rapid heartbeat, confusion or pronounced dizziness); blood in your stool; or fever alongside gut symptoms.
Severe, persistent stomach pain that radiates towards the back (with or without vomiting) needs urgent assessment, because acute pancreatitis is a known, if infrequent, serious risk with GLP-1 medicines. The MHRA highlighted this in its January 2026 Drug Safety Update covering the class, and the advice is clear: do not wait and see with that specific symptom pattern. If any of these warning signs appear, stop the injection until you have spoken to a clinician. You can find guidance on the broader spectrum of effects in the Wegovy diarrhoea topic page, including what different durations and presentations can mean.
Most people who reach their maintenance dose find the initial GI disruption has largely passed. If loose stools return after months of settled digestion, the cause is worth investigating rather than attributing automatically to Wegovy. New dietary changes, concurrent medication, illness or a dose increase following a break can all restart gut symptoms. The experience of diarrhoea after six months on Wegovy is a different clinical picture from early-treatment effects and is covered separately. Similarly, if you have recently stopped the injection, bowel changes after stopping Wegovy explains what tends to happen as semaglutide clears the body. Our prescribers discuss side-effect history and current symptoms as part of every clinical review, treatment decisions are always made on the full picture, not a checklist. You can read more about how Wegovy works and who it suits on the Wegovy overview.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.